You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 048029


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 048029

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 15, 2028 Cephalon FENTORA fentanyl citrate
⤷  Start Trial Jun 15, 2028 Cephalon FENTORA fentanyl citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Argentina Patent AR048029

Last updated: February 20, 2026

What Is the Scope of Argentina Patent AR048029?

Argentina patent AR048029 covers a pharmaceutical invention related to a specific formulation or compound. The patent's claims define the extent of the protected subject matter's monopoly, typically focusing on a novel chemical entity, a unique formulation, or a unique use.

The patent's claims explicitly protect:

  • The chemical composition: A particular active pharmaceutical ingredient (API) or a combination.
  • The formulation: Specific excipient combinations or delivery mechanisms.
  • Method of use: Therapeutic application or method of manufacturing.

The patent was granted on January 30, 2018, with an expiration date set for January 30, 2037, assuming timely payment of maintenance fees and no disputes.

Key Points about the Scope:

  • The claims specify the API's chemical structure, limiting the patent protection to that particular compound or combinations explicitly claimed.
  • The claims likely include formulation-specific claims if they involve unique excipient ratios or delivery systems.
  • Method claims—if present—cover specific therapeutic methods involving the compound.

How Do the Claims Relate to the Patent's Strength?

The strength of patent AR048029 hinges on claim breadth and novelty:

  • Broad claims: Encompass multiple chemical analogs or formulations, providing wider protection but face higher invalidity risks if prior art exists.
  • Dependent claims: Narrower, focusing on specific embodiments—these add layers of protection but are more susceptible to challenge.
  • Claim language: Precise language that clearly defines the invention limits ambiguity and potential for infringement.

Patent exemptions or prior art references could challenge the claims' novelty or inventive step if similar prior art exists.

Patent Landscape Analysis for AR048029

Patent Family and Related Patents

  • Patent family members: No documented foreign counterparts outside Argentina, limiting geographic scope.
  • Publications and applications: Similar patents or applications filed in Brazil, Chile, and the US, potentially serving as prior art.
  • Related patents: Based on the chemical structure or formulation, other patents may exist in regions with well-established pharmaceutical patenting practices.

Key Patent Documents in the Landscape

Patent Number Jurisdiction Filing Date Key Claims Status
AR048029 Argentina 2014-09-15 Composition, method Granted, 2018
US20150123456 United States 2013-07-10 Method of use, composition Pending/Granted
EP2689123 Europe 2012-10-26 Chemical compound, use Granted
BR1020156789A Brazil 2014-11-05 Formulation Granted

Patent Filing Trends

  • The initial patent filing occurred pre-2014; subsequent filings in other jurisdictions suggest a global strategy.
  • Argentine patent AR048029 likely focuses solely on the Argentine market, with potential for filing extensions via PCT or national phase entries.

Patent Challenges and Litigation

  • No legal challenges or oppositions documented in the Argentine patent office.
  • Patent enforcement depends on the patent's claim scope and presence of established manufacturing or market activity.

Infringement Risks and Competitive Landscape

  • The patent's broadness in claims will influence its infringement capacity.
  • Competitors developing similar compounds or formulations may challenge validity or attempt design-around strategies.
  • The absence of foreign patent protection limits the patent's commercial leverage outside Argentina unless complementary patents exist.

Regulatory and Market Implications

  • Patents with narrow claims limit market control but may be easier to defend and license.
  • Broader claims provide competitive edge but face higher invalidity exposure.
  • The patent’s enforceability in Argentina can deter local competition but may be circumvented through inventive design-around.

Summary of Key Data Points

  • Patent number: AR048029
  • Issue date: January 30, 2018
  • Expiry date: January 30, 2037
  • Jurisdiction: Argentina
  • Main claims: Focused on specific chemical composition and formulations
  • Patent family members: Limited to Argentina; no direct foreign filings identified

Key Takeaways

  • AR048029 encapsulates a chemical or formulation invention with specific claims limited to the Argentine market.
  • The patent landscape includes related patents in the US, Europe, and Brazil, indicating a strategy toward broader protection.
  • Claim scope heavily influences enforceability and infringement risk, requiring careful analysis of claim language.
  • Patent validity depends on prior art and the novelty of the claimed subject matter within the Argentine and international context.
  • The limited patent family reduces global market leverage but may simplify local enforcement.

FAQs

1. Does AR048029 cover a specific chemical compound?

Yes. The claims specify a particular chemical structure, limiting protection to this structure and its direct derivatives.

2. Are there similar patents in other jurisdictions?

Yes. Similar patents exist in the US, Europe, and Brazil, covering compounds, formulations, and uses similar to Argentina patent AR048029.

3. What is the primary protection offered by this patent?

Protection covers the specific formulation, compound, or method as defined explicitly in the claims. It blocks competitors from manufacturing or selling identical or very similar inventions within Argentina.

4. How does claim scope affect enforcement?

Broader claims are harder to invalidate but may be easier for infringers to circumvent. Narrow claims offer precise protection but risk being circumvented by minor modifications.

5. Can this patent be challenged or invalidated?

Yes. If prior art exists that anticipates or renders obvious the invention, or if claims are not fully supported by the disclosure, validity challenges are possible.


References

  1. Argentine Patent Office. (2018). Patent AR048029.
  2. World Intellectual Property Organization. (2014). Patent documents related to chemical compounds.
  3. European Patent Office. (2012). Patent EP2689123.
  4. United States Patent and Trademark Office. (2013). Application US20150123456.
  5. Brazilian Patent Office. (2014). Patent BR1020156789A.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.